XML 58 R43.htm IDEA: XBRL DOCUMENT v3.22.4
Collaboration Agreements And Business Development Activities - GSK (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 30, 2022
Dec. 31, 2021
Jan. 01, 2021
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Collaboration agreement percent of royalty on net sale 3.00%    
Collaborative Arrangements with GSK and Royalty Pharma      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Royalty expense $ 58.2 $ 46.6 $ 32.7